Last reviewed · How we verify

NCT05898295: GOCSM

Assessment of the Behavior of the Preterm Newborns

Status unknown Last updated 12 June 2023
What this trial tests

trial testing no intervention in Premature Birth in 100 participants. Status unknown.

Timeline
19 February 2021
Primary endpoint
31 December 2024
31 December 2024

Quick facts

Lead sponsorUniversity Hospital, Geneva
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date19 February 2021
Primary completion31 December 2024
Estimated completion31 December 2024
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Geneva

Who can join

Adults 3 Days to 6 Months, any sex, with Premature Birth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The project presented here aims to evaluate the discrimination capacity of the Observation of Sensory-Motor Behavior (OSMB) grid of the preterm infant, as well as its predictive capacity for the child's later psychomotor development. To do this, OSMB grids will be completed during dystimulant care and during stabilizing care in 65 preterm infants. In addition, an OSMB grid will also be completed during a sensorimotor assessment at 37 weeks gestational age and at 1 month corrected for prematurity in 100 preterm infants. The OCSM scores will then be compared to the Bayley III scale scores at 6 months of age corrected for prematurity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of no intervention

Trials testing the same drug.

Other recruiting trials for Premature Birth

Currently open trials in the same condition.

Other University Hospital, Geneva trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05898295.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing